fashion -WSS

fashion

author：hotspot 2025-09-06 04:27:13 - browse：91139

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Living with Fabry disease, a condition that causes chronic pain

hotspot

WSS

How the political right came to back psychedelics to treat trauma

Retired US general questions alleged Putin, Prigozhin meeting

NIH fellows want a pay raise. Will that mean less money for grants?

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

STAT readers on older presidents, polypills, Medicare, and more

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

leisure time

fashion

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

N.Y. state detects polio case, first in the U.S. since 2013

State Dept. review finds Biden bears some blame for Afghanistan failures

NIH fellows want a pay raise. Will that mean less money for grants?

United colonoscopy coverage change 'may cost lives,' doctors say

In utero gene editing: an explainer

After affirmative action ruling, medical educators look to 'holistic review'

The Harvard botanist who searched for psychedelics in the Amazon

Anesthesiologist group: stop taking Ozempic before surgery

Dario to buy mental health app maker Twill in cash and stock deal

focus

NIH fellows want a pay raise. Will that mean less money for grants?

A solution to the after

Medicare inequities exacerbate Puerto Rico’s health disparities

Petition to FDA: Get the lead out of consumer hair dyes

Charles Manson follower Leslie Van Houten released from prison after 53 years

Why ADHD is under

leisure time

hotspot

focus

hotspot